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In Portugal, the epidemiological stage for the spread of carbapenemase-producing
Enterobacteriaceae (CPE) increased from sporadic isolates or single hospital
clones (2010–2013), to hospital outbreaks, later. Here we report data from a 6-
month study performed under the European Survey on Carbapenemase-Producing
Enterobacteriaceae (EuSCAPE). During the study period, 67 isolates (61 Klebsiella
pneumoniae and 6 Escherichia coli) non-susceptible to carbapenems were identified in
participant hospital laboratories. We detected 37 blaKPC−type (including one new variant:
blaKPC−21), 1 blaGES−5, and 1 blaGES−6 plus blaKPC−3, alone or in combination with
other bla genes. Bioinformatics analysis of the KPC-21-producing E. coli identified the
new variant blaKPC−21 in a 12,748 bp length plasmid. The blaKPC−21 gene was harbored
on a non-Tn4401 element, presenting upstream a partial ISKpn6 (1ISKpn6/1traN)
with the related left IR (IRL) and downstream a truncated Tn3 transposon. PFGE and
MLST analysis showed an important diversity, as isolates belonged to distinct PFGE
and STs profiles. In this study, we highlighted the presence of the high-risk clone E. coli
sequence-type (ST) 131 clade C/H30. This worldwide disseminated E. coli lineage was
already detected in Portugal among other antibiotic resistance reservoirs. This study
highlights the intra- and inter-hospital spread and possible intercontinental circulation of
CPE isolates.
Keywords: carbapenemase-producing Enterobacteriaceae, KPC-21, EuSCAPE, Portugal, Klebsiella pneumoniae,
Escherichia coli
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INTRODUCTION
Carbapenems, a class of β-lactam antibiotics with wide
activity, are often the antimicrobials of last resort to treat
infections associated to extended-spectrum β-lactamase
(ESBL)- or plasmid-mediated AmpC (PMAβ)-producing
Enterobacteriaceae isolates (Papp-Wallace et al., 2011;
Rodríguez-Baño et al., 2018). Unfortunately, carbapenem
non-susceptible Enterobacteriaceae (CNSE) have been reported
worldwide mainly because of the acquisition of carbapenemase-
encoding genes (Potter et al., 2016; Codjoe and Donkor, 2018).
Since the first description of a carbapenemase-producing
Enterobacteriaceae (CPE) in Europe in the 1990s, a large
variety of carbapenemases has been identified in each of the
four Ambler molecular classes, mainly the KPC-type (class
A), VIM-, IMP-, and NDM-types (class B), and OXA-48-type
(class D) (Grundmann et al., 2017; Logan and Weinstein,
2017). CPE isolates are usually resistant to many other β-lactam
and non-β-lactam antibiotics, leading to multi-resistant
isolates.
In Portugal, the epidemiological stage for the spread
of CPE increased from sporadic isolates or single
hospital clones, from April 2010 to February 2013, to
sporadic hospital outbreaks later (Albiger et al., 2015;
Manageiro et al., 2015b,c). Here we report data from a 6-
month prevalence study performed under the European
Survey on Carbapenemase-Producing Enterobacteriaceae
(EuSCAPE) with the collaboration of different Portuguese
Laboratories.
MATERIALS AND METHODS
Bacterial Isolation, Antibiotic
Susceptibility, and Molecular
Characterization
This study included a total of 104 clinical isolates (94
Klebsiella pneumoniae and 10 Escherichia coli) collected
from November 2013 to April 2014 in 10 Portuguese hospitals.
The first ten consecutive and non-replicated CNSE isolates
obtained during this period, in each hospital, from blood,
lower respiratory tract secretions, urine, puncture fluids,
and wound secretions, of single patients, were sent to
the National Reference Laboratory, in Lisbon, and were
considered. Successive carbapenem-susceptible isolates of
the same species were also preserved as controls whenever
possible, accordingly to EuSCAPE protocol (Grundmann
et al., 2017). Overall, 67 CNSE (61 K. pneumoniae and 6
E. coli) and 37 controls (33 K. pneumoniae and 4 E. coli) were
analyzed.
In the context of the EuSCAPE study, all data were
anonymized and collected in accordance with the European
Parliament and Council decisions on the epidemiological
surveillance and control of communicable disease in the
European Community (Eur-Lex-31998D2119, 1998; Eur-Lex-
32000D0096, 2000).
Antibiotic Susceptibility and Molecular
Characterization of Antimicrobial
Resistance
Antimicrobial susceptibility was performed by disk diffusion
method for 15 antibiotics (Table 1), and by broth microdilution
method for tigecycline and colistin, using EUCAST guidelines1.
Clinical isolates with resistance or with decreased susceptibility
to ertapenem were considered presumptively CPE. Isolates
were considered multidrug resistant when presenting
reduced susceptibility to three or more structurally unrelated
antibiotics.
PCR and sequencing were applied to detect and identify the
main CPE (blaKPC and blaGES from class A; blaIMP, blaVIM,
and blaNDM from class B; and blaOXA−48 from class D)-, ESBL
(blaTEM, blaSHV, blaOXA, blaCTX−M) – and PMAβ (blaCMY,
blaMOX, blaFOX, blaLAT, blaACT, blaMIR, blaDHA, blaMOR,
blaACC)-encoding genes, as previously described (Manageiro
et al., 2015b). Plasmid-mediated colistin resistance-encoding
genes (mcr-type) were also investigated (Manageiro et al.,
2017).
Transfer Experiments
Transferability of blaKPC−21 from E. coli UR19829 was
performed by broth mating out assays using sodium
azide-resistant E. coli J53 as a recipient strain, and by
transformation, as previously described (Manageiro et al.,
2015b, 2017).
Molecular Typing
Clonal relatedness of 67 CNSE isolates was investigated
by pulsed-field gel electrophoresis (PFGE) as previously
described (Manageiro et al., 2017). Genetic diversity of the
K. pneumoniae (n = 10, i.e., 1 representative of each PFGE
cluster) and E. coli (n = 10) isolates was investigated by
multilocus sequence typing (MLST) (Manageiro et al., 2015b).
E. coli sequence type (ST) subclones were also analyzed
on the basis of the E. coli fimH gene (Manageiro et al.,
2015a).
Genomic Characterization of
KPC-21-Producing E. coli
KPC-21-producing E. coli was genotypically characterized by
whole-genome sequencing (WGS) as previously described
(Manageiro et al., 2017). The assembled contigs were analyzed
and studied for the presence of antibiotic resistance- and
virulence-encoding genes, multi-locus sequence types, fim type,
serotype, plasmid replicon types, and insertion sequences (ISs)
using bioinformatics tools from the Center for Genomic
Epidemiology2 and ISsaga (Varani et al., 2011).
The pUR19829-KPC21 plasmid structure was constructed
based on the genetic organization of the closest plasmid
1http://www.eucast.org/clinical_breakpoints/
2https://cge.cbs.dtu.dk/services/
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sequences obtained by BLASTn, provided by NCBI3, followed by
contig neighbor’s prediction from assembly information.
Statistical Analysis
OpenEpi software, version 3.01 was used for statistical analysis
(Sullivan et al., 2009). Fisher exact test was used to assess
differences in clinical and epidemiological risk factors for control
and CNSE-carrying patients. One-tailed P values of ≤0.05
were considered to be statistically significant. Associations were
determined by calculation of odds ratios with 95% confidence
intervals.
Nucleotide Sequence Accession Number
The new blaKPC−21 nucleotide sequence was submitted to the
NCBI GenBank Database with accession number NG_049254
and the complete plasmid sequence of pUR19829-KPC21 with
accession number MH133192.
RESULTS AND DISCUSSION
During the study period, 67 isolates (61 K. pneumoniae and
6 E. coli) CNSE were identified in nine of the 10 Hospital
Laboratories, with a non-susceptibility rate for meropenem and
imipenem of 64 and 59%, respectively, for K. pneumoniae,
3http://blast.ncbi.nlm.nih.gov/Blast.cgi
and of 100% for E. coli. As expected, when compared with
the control isolates, CNSE presented higher level of non-
susceptibility to all antibiotic classes tested (Table 1). Colistin
and tigecycline MIC50 values for CNSE were similar than
those obtained for control isolates. Eleven out of the 104
(16.3%) isolates were colistin resistant, without the presence of
the plasmid-mediated mcr-1 or mcr-2 gene. However, MCR-
1 determinant was already identified in different reservoirs
in Portugal, such as vegetables, animals and humans (Jones-
Dias et al., 2016; Beyrouthy et al., 2017; Kieffer et al.,
2017).
Thirty-eight (56.7%) isolates (36 K. pneumoniae, 2 E. coli)
were confirmed to be CPE; we identified 36 blaKPC−type
(including one new variant: blaKPC−21), 1 blaGES−5, and 1
blaGES−6 plus blaKPC−3, alone or in combination with other
bla genes (Supplementary Figure S1). The remaining 29
isolates were non-susceptible to carbapenems possibly due to
porins deficiency with association of PMAβ (CMY-2 and DHA-
1) and/or ESBL (mainly CTX-M-15) production (Martínez-
Martínez, 2008).
The new blaKPC−21 gene differed from blaKPC−2 by one point
mutation that leads to the amino acid substitution Trp105Arg;
this position is involved in the binding and maintaining of
the KPC catalytic activity (Papp-Wallace et al., 2010). In silico
typing revealed an KPC-21-producing E. coli belonging to ST131
clade C/H30, associated with the fimbriae-encoding fimH allele
30, which become the most dominant lineage since the 2000s
TABLE 1 | Antimicrobial susceptibility of 67 (61 K. pneumoniae and 6 E. coli) CNSE and 37 (33 K. pneumoniae and 4 E. coli) control isolates.
Antibiotic K. pneumoniae E. coli
Control (n = 33) CNSE (n = 61) Control (n = 4) CNSE (n = 6)
IR (%) S (%) IR (%) S (%) IR (%) S (%) IR (%) S (%)
Ampicillin 100 0 100 0 100 0 100 0
Amoxicillin/Clavulanate 30 70 89 11 25 75 100 0
Piperacillin/Tazobactam 58 42 98 2 25 75 100 0
Cefotaxime 30 70 92 8 25 75 100 0
Ceftazidime 36 64 95 5 25 75 100 0
Cefepime 36 64 90 10 25 75 100 0
Aztreonam 30 70 92 8 25 75 100 0
Imipenem 0 100 59 41 0 100 100 0
Meropenem 0 100 64 36 0 100 100 0
Ertapenem 0 100 100 0 0 100 100 0
Ciprofloxacin 36 64 69 31 25 75 100 0
Gentamicin 21 79 64 36 50 50 83 17
Tobramycin 33 67 74 26 50 50 83 17
Amikacin 0 100 18 82 0 100 17 83
SXT 33 67 90 10 50 50 67 33
Colistin∗ 6 94 11 89 0 100 0 100
MIC50 1 1 1 1
MIC90 2 4 2 2
Tigecycline∗ 39 61 56 44 0 100 33 67
MIC50 1 2 0.5 0.5
MIC90 4 4 1 4
∗Microdilution method.
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FIGURE 1 | Schematic representation of KPC-21-harboring plasmid (pUR19829-KPC21). Genes are denoted by arrows. Blue, antibiotic resistance genes; Green,
mobile genetic elements; Yellow, plasmid mobilization genes and replication origin. Right and left inverted repeats (IRR and IRL) are indicated as red triangles. Gray
regions 1: 99.97% of identity with KX756453, and Gray region 2: >99.9% sequence identity to KT896499.
(Nicolas-Chanoine et al., 2014; Pitout and DeVinney, 2017).
Moreover, bioinformatics analysis of the KPC-21-producing
E. coli identified this variant in a 12,748 bp length plasmid,
with a mean coverage of 580-fold and GC content of 58.5%
(Figure 1).
Dissemination of blaKPC has been mainly supported by
the horizontal transfer of Tn4401-type transposon, which
harbors tnpA encoding a transposase, tnpR encoding resolvase,
and two insertion sequence elements (ISKpn7 and ISKpn6)
bracketing the blaKPC gene (Cuzon et al., 2011). In this
study, the blaKPC−21 gene was harbored on a non-Tn4401
element (Chen et al., 2014), presenting upstream a partial
ISKpn6 (1ISKpn6/1traN) with the related left IR (IRL)
and downstream truncated Tn3 transposon downstream
(Figure 1). This region has 99.97% of identity with pKP1194a,
a plasmid carried by a hospital-associated KPC-2-producing
K. pneumoniae isolated in Brazil (Accession number KX756453)
(Figure 1- gray region I); this suggest an intercontinental
circulation of isolates and mobile genetic elements (MGE),
and the consequent need of concerted actions against the
spreading of antibiotic resistance, at a worldwide level. The
pUR19829-KPC21 enclosed also an intact ISPsp7 element,
an insertion sequence from IS30 family, firstly described in
Pseudomonas spp. (Szuplewska et al., 2014). Furthermore,
the pUR19829-KPC21 backbone contained a region coding
for plasmid replication (IncQ2 repA, repC), and mobilization
(mobA, mobC), showing >99.9% sequence identity to the
corresponding regions of pKPSH169, a 7.7 Kbp qnrS2-
harboring IncQ plasmid identified in municipal wastewater
treatment facilities in Israel (Accession number KT896499)
(Figure 1- gray region II); this similarity highlights the high
level of promiscuity of isolates between clinical settings
and environment, where both reservoirs play a role in the
antibiotic resistance dissemination (Stokes and Gillings,
2011). However, the lack of conjugative elements or an
oriT region, associated with the presence of a truncated
oriV region (Figure 1) suggests that pUR19829-KPC21
plasmid is nonmobilizable (Smillie et al., 2010). This fact is
corroborated by the absence of a successful plasmid conjugation
or transformation.
The variables used in the evaluation of risk factors for
infection or colonization of patients with CNSE or control
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TABLE 2 | Evaluation of risk factors for patients with infections caused by carbapenem susceptible or CNSE bacteria.
Variables CNS isolates (no.) Control isolates (no.) OR 95% CI P value
Region of patient admission
North 20 13 0.7874 0.3094–2.038 0.3666(P)
Center 11 1 6.977 0.9398–312.7 0.03098
LVT 36 23 0.7092 0.2848–1.726 0.2670(P)
Patient age
≤18 years old 3 1 1.68 0.1294–91.01 0.5522
19–64 22 12 1.018 0.401–2.66 0.5727
≥65 37 18 1.299 0.5389–3.146 0.3305
Unknown 5 6 – – –
Patient gender
Female 31 18 0.9098 0.3769–2.197 0.4885(P)
Male 35 14 1.787 0.7359–4.453 0.1142
Unknown 1 5 – – –
Bacteria vs. host infection
Colonization 0 2 0 0.0–2.912 0.1243(P)
Infection 28 22 0.493 0.1989–1.194 0.06393(P)
Unknown 39 13 – – –
Type of infection
Community Onset 26 15 0.9307 0.3804–2.305 0.5127(P)
Hospital Acquisition 31 11 2.022 0.8072–5.311 0.07451
Unknown 10 11 – – –
Local of infection
Urinary tract infection 39 21 1.061 0.4334–2.574 0.5242
Blood infection 8 4 1.117 0.2737–5.463 0.5679
Pus production with bacteria 7 1 4.155 0.5004–194.5 0.1502
Lower respiratory tract infection 4 3 0.7219 0.1148–5.215 0.4825(P)
Other infections 8 2 2.356 0.4353–24 0.2365
Unknown 1 6 – – –
ESBL production
Positive 37 8 4.406 1.66–12.87 0.0007772
Negative 30 29 0.227 0.0777–0.6024 0.0007772 (P)
Total 67 76
OR, odds ratios; CI, 95% confidence intervals. (P) indicates a one-tail P-value for protective or negative association. One-tailed P values of ≤ 0.05 are underlined. LVT,
Lisbon and Tagus Valley.
isolates are present in Table 2. When compared to the 37
control strains, only ESBL-production and the patient admission
at a hospital in the center of Portugal were significantly
associated with CNSE isolates in the period of the study. In
the era of ESBL-producing Enterobacteriaceae, the antibiotic
regimens suggested for severe health-associated infections are
necessarily based on carbapenems (Rodríguez-Baño et al.,
2018). Unfortunately carbapenem use has being described as
a risk factor for CPE acquisition, only preceded by the use
of medical devices (van Loon et al., 2018). In addition, the
present study attests that Portugal, during the period of the
study, has a different CNSE geographical distribution with the
center of Portugal significantly associated with carbapenem
non-susceptibility. This fact corroborates previous studies
which indicated that in Portugal, in 2015, only sporadic
isolates or single hospital cases were described (Albiger et al.,
2015).
PFGE and MLST analysis showed an important
diversity, with isolates belonging to distinct PFGE and STs
(Supplementary Figure S1). With respect to K. pneumoniae
(Supplementary Figure S1A), a total of 10 clusters and 25
unique PFGE profiles were generated using XbaI, indicating the
that the circulating clones in that period were genetically diverse.
However, carbapenemase-producing K. pneumoniae isolates
were more clonal (six PFGE clusters including 69.4% of these
isolates) than non-carbapenemase-producing K. pneumoniae
(four PFGE clusters including 50.0% of these isolates). As
shown in Supplementary Figure S1, both CNSE species
showed intra- and inter-hospital spread (e.g., PFGE clusters
KpI and KpIX), with some hospital-specific clones (e.g., PFGE
clusters KpIV and KpVIII). However, as also showed in Spain
in other EuSCAPE study (Esteban-Cantos et al., 2017), the
carbapenem-non-susceptible K. pneumoniae population was
more clonal than the carbapenem-susceptible population
(data not shown). Ten different MLSTs were detected among
carbapenemase-producing (ST14, ST15, ST45, ST231, and
ST1513) and non-carbapenemase-producing (ST11, ST17,
ST348, and ST395) K. pneumoniae isolates. At our knowledge,
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this is the first description of ST17, ST395, and ST1513
K. pneumoniae in Portugal (Manageiro et al., 2015b; Rodrigues
et al., 2016; Vubil et al., 2017). Noteworthy, the GES-5
enzyme was detected in a ST231 K. pneumoniae isolate as
previously reported in Portugal, but in the same hospital,
which shows its capacity to maintain in clinical settings due to
the selection pressure of this environment (Manageiro et al.,
2015b). Furthermore, ST45 was recently the cause of a hospital-
based outbreak caused by multidrug-resistant, KPC-3- and
MCR-1-producing K. pneumoniae in Portugal (Mendes et al.,
2018).
The high-risk clone carbapenemase-positive K. pneumoniae
ST258 was not detected in this study or among clinical
carbapenemase-producing K. pneumoniae isolates in Portugal
(Manageiro et al., 2015b; Rodrigues et al., 2016; Vubil
et al., 2017). However, concerning carbapenem-non-susceptible
E. coli, besides the six different PFGE unique profiles, the
isolates belongs all but two (ST405-fimH27 and ST23-fimH35)
to the ST131 clade C/H30 high-risk clone disseminated
worldwide (Supplementary Figure S1B) (Woodford et al.,
2011; Pitout and DeVinney, 2017). Noteworthy, this clone
was already detected in Portugal among other antibiotic
resistance reservoirs, such as in an E. coli strain isolated
from a dolphin housed at a Zoo Park (Manageiro et al.,
2015a); in dogs and cats with urinary tract infection (Marques
et al., 2018); and in E. coli strains from wastewater and
gulls (Varela et al., 2015). Again, this shows that clinical
settings and different environmental compartments may be
considered communicating vessels through which bacteria
and resistance genes are able to flow (Stokes and Gillings,
2011).
Portugal was one of the EuSCAPE participating countries that
presented higher proportions of KPC-positive K. pneumoniae
(Grundmann et al., 2017). The percentage of carbapenem non-
susceptible K. pneumoniae was low in invasive infections
in the study period [2.4%, EARS-Net 2013]4. However,
although the consumption of carbapenems has declined by
13.3% between 2012 and 2016 (PPCIRA, 2017), Portugal
is reporting since 2013 a significant increasing trend of
carbapenem non-susceptible K. pneumoniae [6.4%, EARS-
Net 2016]4. The number of inter-institutional transmission
is also increasing (Glasner et al., 2013; Albiger et al., 2015),
being K. pneumoniae the principal cause of bacterial health-
associated infections in Portugal, as in other European
countries (ECDC, 2013). Of concern is the fact that KPC-
producing organisms cause infections with high morbidity
and mortality (Porreca et al., 2018; Rodríguez-Baño et al.,
2018). These results reinforces that reducing antibiotic
use alone is likely insufficient for reversing resistance
(Lopatkin et al., 2017). We strongly believe that the chain
of transmission of isolates and genes in clinical settings
will be reduced or broken, especially with containment
measures rigorously implemented and followed at local
level.
4https://ecdc.europa.eu/
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FIGURE S1 | Pulsed-field gel electrophoresis (PFGE) dendrogram and genetic
relatedness of 61 K. pneumoniae (A) and 6 E. coli (B) CNSE isolates. Isolate
number, hospital code, year of isolation, carbapenems antibiotic susceptibility,
detected carbapenemases, extended-spectrum β-lactamases (ESBL), inhibitor
resistant SHV (IRS), and plasmid-mediated AmpC (PMAβ), Multilocus sequence
typing (MLST) for selected isolates and PFGE profile types are shown. These
profiles, from 0001 to 0035, were defined as forming clusters KpI to KpX, for
K. pneumoniae, and from 0001 to 0006 for E. coli. For E. coli isolates, fim-type is
also shown.
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